USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 76 – 100 of 4875 Awards
Company: GENOMICS USA, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … prototype (microarrays, PCR reagents, Hybridization Reagents, Specialized Software) for subsequent Beta Testing. This kit will be prepared under manufacturing control (ISO 13845) similar to the HLA-Chip products from GenUSA which are currently being launched into tissue… more
Company: GLSYNTHESIS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …mster flank, reduced the size of this organ but only on the ipsilateral side These results suggest that this drug is a soft antiandrogen , expected to be active topically inandrogen-dependent maladies of the skin and scalp, but to be hydrolyzed by plasma or tissue enzymes, thus… more
Company: ADVAITA CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … medicine and drug discovery. To realize the much-heralded promise of personalized medicine, it is necessary to (a) accurately recognize and distinguish disease subtypes, (b) apply these diagnostic signatures at the level of the individual patient (and tissue type) over… more
Company: HIGH THROUGHPUT GENOMICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … in Phase I. This platform uses a nuclease protection assay combined with universal PCR to produce targeted sequencing libraries. The lysis-only protocol means there is no need to extract RNA or DNA or to reverse transcribe RNA. Consequently, sequencing from fixed tissue is… more
Company: CAPRICOR, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … cells (CDCs), grown from a donor unrelated to the recipient, using a proprietary process exclusively licensed to Capricor. Autologous CDCs have demonstrated their utility as a regenerative agent: able to reduce infarct size (a.k.a scar size), add viable tissue mass, and… more
Company: CELDARA MEDICAL, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … due to associated toxicities. We have focused on targeting Plasmalemmal Vesicle Associated Protein-1 (Plvap/PV1), an endothelial specific protein with roles in angiogenesis8-10 and diapedesis of leukocytes11. PV1 is expressed on a subset of endothelia in normal … more
Company: IMMUNOMEDICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …. However, prior to initiating clinical studies, Immunomedicswill need to have a required PK/acute toxicity study performed in a relevant animal species (monkeys), an immunohistology study following the Points to Consider, showing the reactivity of the TF10 bsMAb with tissues,… more
Company: ENANTIGEN THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … (HBV) covalently closed circular DNA (cccDNA) formation and/or maintenance. HBV cccDNA is essential to the virus life cycle and its elimination during chronic infection is considered critical to durable therapy. However, because of the limitations of current HBV tissue… more
Company: GLYCOMIRA, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of this inflammatory process to the deeper periodontal ligaments and alveolar bone… more
Company: NEOSTEM, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Scleroderma is an autoimmune, connective tissue disorder which causes fibrosis of the skin and internal organs. In the skin, there is overproduction of extracellular matrix, and type 1 and 3 collagen. The disease involves vascular breakdown… more
Company: Operative Experience, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: …. Operative Experience, Inc. proposes to meet this requirement through the development of a training program based on an anatomically accurate, vascularized, human body simulator with standardized size and weight, standardized artificial blood vessels and tissues, standardized… more
Company: INNOVATIVE BIOTHERAPIES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …H RELEVANCE PUBLIC HEALTH RELEVANCE: The goal of this proposal is to develop a compact Selective Cytopheretic Device (cSCD), an extracorporeal membrane device that can sequester activated leukocytes and inhibit their inflammatory activity in order to reduce tissue accumulation… more
Company: Innovative Surface Technologies, Inc. Agency/Program/Year/Phase: NSF / SBIR / 2013 / 1
Abstract: … will develop a new generation of thermoresponsive cell cultureware that could gain wide market acceptance, and become an enabling technology. The process uses simple equipment, is manufacture-friendly, cost-effective, and is available in formats needed for tissue engineering… more
Company: IONWERKS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): MALDI tissue imaging, when enabled by Nanoparticulate (NP) Matrix implantation, is maturing into a useful preclinical tool for biomarker and drug discovery in our laboratory and at NIDA-IRP. Quantitatively reproducibleimages from serial… more
Company: Kitware Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: … extremely low frequency emissions (ELF) influence hair dryer design as well as power-line placement. Cell-phones are scrutinized using measures of radiation absorption. Laser pointers, police traffic radars, and microwave ovens must also be designed using models of the tissues… more
Company: Kitware Inc. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: … goal is to continue to demonstrate its wide applicability and utility by customizing the method for serial chest CT registration. Second, it is hypothesized that using physically-inspired heuristics to model the patient-specific, inhomogeneous elasticity of lung tissue will… more
Company: Kitware Inc. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: …vided by applicant): This application addresses Innovations in Biomedical Computational Science and Technology Initiative PAR-09-220. Healthcare is moving towards fully digitized patient records. Surgical pathology represents a challenge inthat high resolution imaging of tissue… more
Company: L2 DIAGNOSTICS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …ce in the presence of an adjuvant. We will demonstrate that this immunization protocol results in the appearance of anti-Borrelia antibodies. Immunized animals will then be challenged with 104 live Borrelia spirochetes. Twenty-one days after challenge we will collect tissue… more
Company: LIGHT AGE, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Recent advances in photoacoustic tomography (PAT) have demonstrated its potential for 3D noninvasive high resolution imaging of soft tissues at penetration depths of many centimeters. Further, and perhaps even more importantly, imaging of… more
Company: LUCIGEN CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … control of gene expression using long-wavelength (700-750 nm) light. In addition to avoiding the side effects and costs associated with drug-based systems, light-inducible control offers the advantages of precise spatial and temporal targeting of individual tissues and… more
Company: LUCIGEN CORPORATION Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The genetic basis of disease remains a significant research problem, impacting the fields of cancer biology, neurology, cardiology, development, and even microbiology, as recently realized by the Human Microbiome Project. Determination of the genomic sequence… more
Company: MEDICAL IMAGING APPLICATIONS, LLC Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: … for quantitative assessment of 3D and 4D aortic image data from MR and MDCT, the resultsof recent NIH-funded research at the University of Iowa, to clinical applicability. No such analyses are currently commercially available for either assessment of connective tissue… more
Company: MICROBRIGHTFIELD, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … destination in the brain). Accordingly, investigators have attempted for more than 30 years to trace, reconstruct, visualize and quantitatively characterize the microscopic three-dimensional (3D) micro-angioarchitecture of the brain in normal and pathological tissue (3D… more
Company: MODULATED IMAGING, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Quantitative characterization of tissue structure and function is one of the most challenging problems in Medical Imaging. Field of view, depth of interrogation, and resolution are critical features that dramatically impact image quality and… more
Company: MOLECULAR TARGETING TECHNOLOGIES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … gained from a given model organism. Specifically, our Specific Aims are: (1) Synthesize four spectrally distinct fixable lipophilic dyes, three for nerve tract tracing andone or blood vessel labeling, that are compatible with standard fixation techniques used in tissue… more
Displaying 76 – 100 of 4875 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.